Exchange: NASDAQ·Updated 07:59 PM EDT
OTLK logo

OTLK Outlook Therapeutics Inc

$0.4681
$0.0254
(5.15%)
Today
Closed $0.4681
$0.0059
(1.26%)
After Hours
EarningsDec 18
Mkt Cap$113.96M
Vol4.79M

About OTLK

Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of ONS-5010/LYTENAVA. Its pipeline includes unmet patient needs, repackaged IV bevacizumab, and anti-VEGF. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Iselin, NJ.
62

Bullish Sentiment

How do you feel about OTLK?

adayxs
$OTLK This really is very simple unlike the approval process. They prove they will make this hit the numbers and the value will flow in. If they beat the numbers with a good margin things will get wild. If they miss we all know what will happen. You cannot time it. This is a hold and look at out of interest not crazy anticipation about what could happen tomorrow. Longs know how the value arrived here. That clown is gone. I still see us being happy one day.
15
RZLV_MakesMeRich
$OTLK just sold five MSFT shares and bought 5000 OTLK shares. Let's see if it will be worth it!
23
ALOSETE
$OTLK This stock looks clearly controlled and manipulated since the opening bell. The price action feels anything but natural. It seems like someone is deliberately keeping the price under tight control. The big question is WHY and for how long. Something doesn't add up here. 👀🔥
1
14
CurlyBear
$OTLK I’ve been involved here for nearly 2 years now. I just doubled my position. My average cost is low now—thanks! Let’s keep going from here. 👍
16
adayxs
$OTLK Stop being so jumpy This is how it will be until they prove they will make it work. Don't let the pumpers get you worked up thinking any move means anything. It does not.
15
Tom2772
$OTLK I could list countless milestones already achieved and still to come, but I’ll use just one word UNDERVALUED!
21
IniG
$OTLK Whenever they post this, they have some news to share in a week or so. Probably the launch news next week?
1
16
Tom2772
$OTLK KOD above $90 while OTLK is fighting to hold $0.52. In my opinion, this is one of the biggest market absurdities of all time. One has an FDA approved product ready for commercialization. The other commands a multibillion dollar valuation. At some point, execution will have to speak louder than sentiment.
17
HarveySpecter20
$OTLK with those numbers OTLK has some really serious short squeeze potential, but it would require some major positive news 🥲
14
Enea1977
$OTLK I miss the days when there were just a handful of us talking about truly serious matters.
12
ALOSETE
$OTLK I'm BUYING aggressively at these levels! The market is pricing Outlook Therapeutics as if LYTENAVA were already a TOTAL FAILURE. That's absolutely ridiculous in my opinion! We're talking about an FDA-approved drug with a massive market opportunity, yet the stock is being treated like a bankrupt company. If commercialization delivers even a fraction of its potential, this valuation could look completely absurd. Extreme pessimism creates extreme opportunities. 🚀💰 $OTLK #Bullish
1
14
Tom2772
$OTLK It currently looks like all you need for another green day is hope and potential, no product revenue, not even a BLA submission. Just look at KOD: positive Phase 3 data and a planned BLA filing are enough to fuel optimism, that’s currently enough for a $5.3B market cap. Meanwhile, OTLK has a commercial launch approaching, yet apparently that’s only worth another red day and not even a measly $140M market cap. Both KOD and OTLK target the same massive retina market, with overlapping potential in wet AMD. That's biotech. LOL 😉
17
RZLV_MakesMeRich
$OTLK 650.000 shares (40% daily vol) in just one hour of final hours. I smell good news tomorrow, or fish loading up!
14
ALOSETE
$OTLK The market may be seriously underestimating what's coming. 🚀 Objectively, Outlook Therapeutics has strengthened its leadership team with interesting additions in both financial management and commercial operations. The mistakes made in Europe could prove to be invaluable lessons, allowing the company to execute a much sharper, more disciplined and better-focused U.S. launch strategy. Management deserves a vote of confidence. They have a valuable, FDA-approved asset in LYTENAVA and a real opportunity to turn it into a profitable business. Yes, execution and financing risks remain. But in my opinion, the market is pricing $OTLK as if commercial failure were almost inevitable. I believe that pessimism is excessive — and that's precisely where the opportunity lies. The market is focused on past mistakes. I'm focused on what this company could become. Bullish. 🐂📈
15
RZLV_MakesMeRich
$OTLK investing in OTLK is like playing roulette but knowing the next number. An FDA approved drug trading for $0.5 a share? A company that was trading at $2 of just SPECULATIONS of being approved, now that is officially approved, goes for 75% off? At this price, it's basically robbery!
15
Stockholderq
$OTLK you know something big is coming, you’ve been humbled enough, now i’s the right time to boost.
16
LongStockSniper
$OTLK Many people talk too much garbage so it is good to learn to ignore and have a tough skin. Do not get affected by silly people or just shorts who are trying to get under your skin for sharing positive info. No one is forcing them to read your info so just keep sharing the bullish news and lets keep chugging along strongly!!!
13
PNWbuck
$OTLK While the AI bots malfunction in chat, I'm just sitting on my pile of shares waiting on the next battle for 1.70.. or 17 whichever comes first. Now, I'm off to find a new sushi chef!
10
adayxs
$OTLK Pharmacy Liability Concerns: Legal experts note that many major 503B outsourcing facilities (large-scale compounding pharmacies) are expected to stop offering repackaged Avastin for wet AMD entirely to maintain regulatory compliance and avoid federal penalties.
14
Stockholderq
$OTLK share price is getting higher and higher, hope accumulation is done and we’re about to get the news launch soon
15

Advertisement|Remove ads.